Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins.

We investigated the production efficiency and the gene transfer capacity in the central nervous system of HIV-1-based vectors pseudotyped with either the G protein of the Mokola lyssaviruses (MK-G), a neurotropic virus causing rabies disease, or the vesiculo-stomatitis G protein (VSV-G). Both envelopes induced syncitia in cell cultures. They were incorporated into vector particles and mature virions were observed by electron microscopy. Vector production was two- to sixfold more efficient with VSV-G than with MK-G. For equivalent amounts of physical particles, vector titration was 5- to 25-fold higher with VSV-G than with MK-G pseudotypes on cultured cells, and in vivo gene expression in mouse brain was more intense. Thus, VSV-G pseudotypes were produced more efficiently and were more infectious than MK-G pseudotypes. Tropism for brain cells was analyzed by intrastriatal injections in rats. Both pseudotypes preferentially transduced neurons (70-90% of transduced cells). Retrograde axonal transport was investigated by instilling vector suspensions in the rat nasal cavity. Both pseudotypes were efficiently transported to olfactive neuron bodies. Thus, although coating HIV-1 particles with rabdhovirus envelope glycoproteins enables them to enter neuronal cells efficiently, pseudotyping is not sufficient to confer the powerful neurotropism of lyssaviruses to lentivirus vectors.

[1]  N. Tordo,et al.  Evidence of Two Lyssavirus Phylogroups with Distinct Pathogenicity and Immunogenicity , 2001, Journal of Virology.

[2]  A. Kingsman,et al.  Stable gene transfer to the nervous system using a non-primate lentiviral vector , 1999, Gene Therapy.

[3]  E. Hawrot,et al.  Binding of rabies virus to purified Torpedo acetylcholine receptor. , 1986, Brain research.

[4]  O. Schwartz,et al.  Cytosolic Gag p24 as an Index of Productive Entry of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.

[5]  R. Ruigrok,et al.  Low-pH induced conformational changes in viral fusion proteins: implications for the fusion mechanism. , 1995, The Journal of general virology.

[6]  T Friedmann,et al.  Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Robison,et al.  The Membrane-Proximal Stem Region of Vesicular Stomatitis Virus G Protein Confers Efficient Virus Assembly , 2000, Journal of Virology.

[8]  G. Gosztonyi Reproduction of lyssaviruses: ultrastructural composition of lyssavirus and functional aspects of pathogenesis. , 1994, Current topics in microbiology and immunology.

[9]  G. Ugolini,et al.  Propagation of pseudorabies virus in the nervous system of the mouse after intranasal inoculation. , 1994, Virology.

[10]  F. Superti,et al.  Involvement of gangliosides in rabies virus infection. , 1986, The Journal of general virology.

[11]  F. Cosset,et al.  Retroviral Vectors Pseudotyped with Lymphocytic Choriomeningitis Virus , 1999, Journal of Virology.

[12]  R. Ruigrok,et al.  Rabies virus glycoprotein is a trimer , 1992, Virology.

[13]  L. Chieco‐Bianchi,et al.  Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells , 1997, Journal of virology.

[14]  N. Tordo,et al.  Cytoplasmic Dynein LC8 Interacts with Lyssavirus Phosphoprotein , 2000, Journal of Virology.

[15]  C. Aoki,et al.  The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system. , 1995, Virology.

[16]  T. Friedmann,et al.  Separable Mechanisms of Attachment and Cell Uptake during Retrovirus Infection , 2000, Journal of Virology.

[17]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[18]  D. Littman,et al.  Packaging system for rapid production of murine leukemia virus vectors with variable tropism , 1992, Journal of virology.

[19]  M. Davisson,et al.  Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency. , 1989, The Journal of clinical investigation.

[20]  W. Uckert,et al.  Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. , 2000, Virology.

[21]  F. Gage,et al.  Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Doolittle,et al.  Homology between the glycoproteins of vesicular stomatitis virus and rabies virus , 1982, Journal of virology.

[23]  O. Danos,et al.  Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses , 1992, Journal of virology.

[24]  Hideki Mochizuki,et al.  High-Titer Human Immunodeficiency Virus Type 1-Based Vector Systems for Gene Delivery into Nondividing Cells , 1998, Journal of Virology.

[25]  M. Sitbon,et al.  TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions , 1996, Journal of virology.

[26]  M. Suomalainen,et al.  Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus , 1994, Journal of virology.

[27]  H. Rossmann,et al.  Pseudotype Formation of Moloney Murine Leukemia Virus with Sendai Virus Glycoprotein F , 1998, Journal of Virology.

[28]  P. Bates,et al.  Characterization of Ebola Virus Entry by Using Pseudotyped Viruses: Identification of Receptor-Deficient Cell Lines , 1998, Journal of Virology.

[29]  A. Miller,et al.  Retrovirus Vectors Bearing Jaagsiekte Sheep Retrovirus Env Transduce Human Cells by Using a New Receptor Localized to Chromosome 3p21.3 , 2000, Journal of Virology.

[30]  B. Kieffer,et al.  Low‐affinity nerve‐growth factor receptor (P75NTR) can serve as a receptor for rabies virus , 1998, The EMBO journal.

[31]  N. Tordo,et al.  Structure and expression in baculovirus of the Mokola virus glycoprotein: an efficient recombinant vaccine. , 1993, Virology.

[32]  B. Groner,et al.  Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles. , 1999, Virology.

[33]  D. Lindemann,et al.  Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins , 1997, Journal of virology.

[34]  C. Aiken Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A , 1997, Journal of virology.

[35]  F. Cosset,et al.  Incorporation of Fowl Plague Virus Hemagglutinin into Murine Leukemia Virus Particles and Analysis of the Infectivity of the Pseudotyped Retroviruses , 1998, Journal of Virology.

[36]  R. Wollmann,et al.  CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. , 1995, Gene therapy.

[37]  M. Schachner,et al.  The Neural Cell Adhesion Molecule Is a Receptor for Rabies Virus , 1998, Journal of Virology.

[38]  D. Trono,et al.  Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer. , 2000, Human gene therapy.

[39]  S. Karlsson,et al.  Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  L. Chieco‐Bianchi,et al.  Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells , 1998, Gene Therapy.

[41]  J. Garcia,et al.  Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus , 1991, Journal of virology.

[42]  B. Davidson,et al.  Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors , 2000, Neuroreport.

[43]  L Naldini,et al.  Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector , 1997, Journal of virology.

[44]  C. Jallet,et al.  Chimeric Lyssavirus Glycoproteins with Increased Immunological Potential , 1999, Journal of Virology.

[45]  M. Goldsmith,et al.  Distinct Mechanisms of Entry by Envelope Glycoproteins of Marburg and Ebola (Zaire) Viruses , 2000, Journal of virology.

[46]  R. Swanstrom,et al.  Retrovirus envelope glycoproteins. , 1990, Current topics in microbiology and immunology.

[47]  K. Conzelmann,et al.  Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles , 1995, Journal of virology.